BACKGROUND AND OBJECTIVE: African Americans have worse outcomes in colorectal cancer (CRC) than Caucasians. We sought to determine if KRAS, BRAF and PIK3CA mutations might contribute to the racial differences in CRC outcome. METHODS: DNA was extracted from tissue microarrays made from CRC samples from 67 African Americans and 237 Caucasians. Mutations in KRAS, BRAF, and PIK3CA were evaluated by PCR sequencing. We also examined microsatellite instability (MSI) status. Associations of mutation status with tumor stage and grade were examined using a logistic regression model. Cox proportional hazards models were used to estimate the all-cause mortality associated with mutational status, race and other clinicopathologic features. RESULTS: KRAS mutations were more common in African Americans than among Caucasians (37% vs 21%, p=0.01) and were associated with advanced stage (unadjusted odds ratio (OR)=3.31, 95% confidence interval (CI) 1.03-10.61) and grade (unadjusted OR=5.60, 95% CI 1.01-31.95) among African Americans. Presence of BRAF mutations was also positively associated with advanced tumor stage (adjusted OR=3.99, 95%CI 1.43-11.12) and grade (adjusted OR=3.93, 95%CI 1.05-14.69). PIK3CA mutations showed a trend toward an association with an increased risk of death compared to absence of those mutations (adjusted for age, sex and CRC site HR=1.89, 95% CI 0.98-3.65). Among African Americans, the association was more evident (adjusted for age, sex and CRC site HR=3.92, 95% CI 1.03-14.93) and remained significant after adjustment for MSI-H status and combined education-income level, with HR of 12.22 (95%CI 1.32-121.38). CONCLUSIONS: Our results suggest that African Americans may have different frequencies of somatic genetic alterations that may partially explain the worse prognosis among African Americans with CRC compared to whites.
BACKGROUND AND OBJECTIVE: African Americans have worse outcomes in colorectal cancer (CRC) than Caucasians. We sought to determine if KRAS, BRAF and PIK3CA mutations might contribute to the racial differences in CRC outcome. METHODS: DNA was extracted from tissue microarrays made from CRC samples from 67 African Americans and 237 Caucasians. Mutations in KRAS, BRAF, and PIK3CA were evaluated by PCR sequencing. We also examined microsatellite instability (MSI) status. Associations of mutation status with tumor stage and grade were examined using a logistic regression model. Cox proportional hazards models were used to estimate the all-cause mortality associated with mutational status, race and other clinicopathologic features. RESULTS: KRAS mutations were more common in African Americans than among Caucasians (37% vs 21%, p=0.01) and were associated with advanced stage (unadjusted odds ratio (OR)=3.31, 95% confidence interval (CI) 1.03-10.61) and grade (unadjusted OR=5.60, 95% CI 1.01-31.95) among African Americans. Presence of BRAF mutations was also positively associated with advanced tumor stage (adjusted OR=3.99, 95%CI 1.43-11.12) and grade (adjusted OR=3.93, 95%CI 1.05-14.69). PIK3CA mutations showed a trend toward an association with an increased risk of death compared to absence of those mutations (adjusted for age, sex and CRC site HR=1.89, 95% CI 0.98-3.65). Among African Americans, the association was more evident (adjusted for age, sex and CRC site HR=3.92, 95% CI 1.03-14.93) and remained significant after adjustment for MSI-H status and combined education-income level, with HR of 12.22 (95%CI 1.32-121.38). CONCLUSIONS: Our results suggest that African Americans may have different frequencies of somatic genetic alterations that may partially explain the worse prognosis among African Americans with CRC compared to whites.
Entities:
Keywords:
African-Americans; BRAF; KRAS; PIK3CA; colorectal cancer
Authors: Mai Yamauchi; Teppei Morikawa; Aya Kuchiba; Yu Imamura; Zhi Rong Qian; Reiko Nishihara; Xiaoyun Liao; Levi Waldron; Yujin Hoshida; Curtis Huttenhower; Andrew T Chan; Edward Giovannucci; Charles Fuchs; Shuji Ogino Journal: Gut Date: 2012-03-17 Impact factor: 23.059
Authors: Matthew F Kalady; Kathryn L Dejulius; Julian A Sanchez; Awad Jarrar; Xiuli Liu; Elena Manilich; Marek Skacel; James M Church Journal: Dis Colon Rectum Date: 2012-02 Impact factor: 4.585
Authors: Greg Yothers; Daniel J Sargent; Norman Wolmark; Richard M Goldberg; Michael J O'Connell; Jacqueline K Benedetti; Leonard B Saltz; James J Dignam; A William Blackstock Journal: J Natl Cancer Inst Date: 2011-10-12 Impact factor: 13.506
Authors: C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava Journal: Cancer Res Date: 1998-11-15 Impact factor: 12.701
Authors: Krishan Kumar; Hassan Brim; Francis Giardiello; Duane T Smoot; Mehdi Nouraie; Edward L Lee; Hassan Ashktorab Journal: Clin Cancer Res Date: 2009-02-03 Impact factor: 12.531
Authors: Zachary Hurst; Sandya Liyanarachchi; Huiling He; Pamela Brock; Jennifer Sipos; Fadi Nabhan; Electron Kebebew; Patience Green; Gilbert J Cote; Steven Sherman; Christopher J Walker; Yi Seok Chang; Shuai Xue; Brynn Hollingsworth; Wei Li; Luke Genutis; Eric Menq; Albert de la Chapelle; Sissy M Jhiang Journal: Thyroid Date: 2019-02-13 Impact factor: 6.568
Authors: Tyler Hinshaw; Suzanne Lea; Justin Arcury; Alexander A Parikh; Rebecca A Snyder Journal: Cancer Causes Control Date: 2021-01-04 Impact factor: 2.506
Authors: Natalie S X Ren; Ming Ji; Erik J Tokar; Evan L Busch; Xiaojiang Xu; DeAsia Lewis; Xiangchun Li; Aiwen Jin; Yanping Zhang; William K K Wu; Weichun Huang; Leping Li; David C Fargo; Temitope O Keku; Robert S Sandler; Xiaoling Li Journal: Curr Biol Date: 2017-02-02 Impact factor: 10.834
Authors: Krishnansu S Tewari; Michael W Sill; Bradley J Monk; Richard T Penson; Harry J Long; Andrés Poveda; Lisa M Landrum; Mario M Leitao; Jubilee Brown; Thomas J A Reid; Helen E Michael; David H Moore Journal: Clin Cancer Res Date: 2015-12-15 Impact factor: 12.531
Authors: Evan L Busch; Temitope O Keku; David B Richardson; Stephanie M Cohen; David A Eberhard; Christy L Avery; Robert S Sandler Journal: Clin Exp Metastasis Date: 2015-10-27 Impact factor: 5.150
Authors: Frank A Sinicrope; Qian Shi; Thomas C Smyrk; Stephen N Thibodeau; Rodrigo Dienstmann; Justin Guinney; Brian M Bot; Sabine Tejpar; Mauro Delorenzi; Richard M Goldberg; Michelle Mahoney; Daniel J Sargent; Steven R Alberts Journal: Gastroenterology Date: 2014-10-08 Impact factor: 22.682